While precision medicine has focused on tumor biology, this research suggests a broader "precision care" approach is needed. This involves tailoring treatment, such as drug dosage, based on patient-specific factors like physiology, functional reserve, and personal goals, not just genomic markers.

While weightlifting improves metabolism and glucose sensitivity, it doesn't significantly reduce dangerous visceral fat. To target this deep belly fat, aerobic exercises like running, jogging, or cycling are necessary due to their higher energy expenditure and impact on caloric deficit.

Current exercise guidelines suggest a 2:1 ratio of moderate-to-vigorous exercise based on calorie burn. However, new data shows the ratio is closer to 8:1 for reducing death from cardiovascular disease, highlighting the disproportionate value of intensity.

Perform cardiovascular training after weightlifting. The pre-fatigued state from lifting forces your heart to work harder to meet demand, achieving the conditioning goal even with lower output, and it doesn't compromise the intensity of your primary strength workout.

Generic advice like "diet and exercise" is ineffective for cancer patients. Clinicians should adopt a pharmaceutical model, prescribing specific types and "doses" of diet and exercise based on a patient's unique metabolic profile, treatment, and clinical goals, rather than handing out a generic brochure.

Chemotherapy is known to worsen metabolic parameters, but this should be viewed as an opportunity, not just a side effect. By actively correcting this metabolic dysfunction with adjunctive therapies, clinicians may be able to enhance the overall life-saving benefit of the chemotherapy itself.

While beneficial for mobility and general fitness, activities like Pilates and yoga do not provide the sufficient or progressive resistance needed to build and maintain muscle mass long-term. They are not a substitute for dedicated strength training to combat age-related muscle loss.

Data from the CO21 trial shows a structured exercise program provides a 7% improvement in overall survival for high-risk colon cancer patients. This non-pharmacological intervention demonstrates a greater survival benefit than the established 5% gain from adding oxaliplatin to chemotherapy.

The specific exercise you choose (e.g., bench press) does not determine the outcome. Rather, the adaptation (strength vs. endurance) is dictated by variables like intensity, sets, reps, and rest periods. The application of the exercise is the primary driver of results.